Use of Ledipasvir/Sofosbuvir with or without Ribavirin in Patients Post-Liver Transplant: Evaluation of Real-World Datasets

被引：0
|
作者：
Flamm, S. [1 ]
Charlton, M. [2 ]
Manns, M. [3 ]
Prieto, M. [4 ]
Fernandez, I. [5 ]
Londono, M. [6 ]
Kwok, R. [7 ]
Smith, C. [8 ]
Lee, S. [9 ]
Ngo, H. [9 ]
Osinusi, A. [9 ]
Copans, A. [9 ]
Rossaro, L. [9 ]
Shoreibah, M. [10 ]
Massoud, O. [10 ]
Curry, M. [11 ]
Bourliere, M. [12 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
[2] Intermt Med Ctr, Murray, KY USA
[3] Hannover Med Sch, Hannover, Germany
[4] Hosp Univ I Politecn La Fe, Valencia, Spain
[5] Hosp Univ 12 Octubre, Madrid, Spain
[6] Hosp Clin Barcelona, Serv Hepatol, Barcelona, Spain
[7] Walter Reed Natl Mil Med Ctr, Washington, DC USA
[8] Medstar Georgetown Univ Hosp, Georgetown, Guyana
[9] Gilead Sci Inc, Foster City, CA USA
[10] Univ Alabama Birmingham, Birmingham, AL USA
[11] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[12] Hosp St Joseph, Marsielle, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
145
引用
收藏
页码：259 / 259
页数：1
相关论文
共 50 条
  • [31] Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: a real-life strategy
    Donato, Maria Francesca
    Morelli, Cristina
    Romagnoli, Renato
    Invernizzi, Federica
    Mazzarelli, Chiara
    Iemmolo, Rosa Maria
    Montalbano, Marzia
    Lenci, Ilaria
    Bhoori, Sherrie
    Pieri, Giulia
    Berardi, Sonia
    Caraceni, Paolo
    Martini, Silvia
    LIVER INTERNATIONAL, 2017, 37 (05) : 678 - 683
  • [32] Real-World Outcomes of Ledipasvir/Sofosbuvir in Treatment-Naive Patients With Hepatitis C
    Younossi, Zobair M.
    Park, Haesuk
    Gordon, Stuart C.
    Ferguson, John R.
    Ahmed, Aijaz
    Dieterich, Douglas
    Saab, Sammy
    AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 (06): : SP205 - SP211
  • [33] Ledipasvir/Sofosbuvir plus /-Ribavirin in Patients Co-infected with HCV and HIV: Real-world Heterogeneous Population from the TRIO Network
    Dieterich, Douglas
    Bacon, Bruce
    Curry, Michael
    Flamm, Steven
    Guest, Lauren
    Kowdley, Kris V.
    Lee, Yoori
    Tsai, Naoky
    Younossi, Zobair M.
    Afdhal, Nezam H.
    GASTROENTEROLOGY, 2016, 150 (04) : S1041 - S1041
  • [34] LEDIPASVIR/SOFOSBUVIR plus /-RIBAVIRIN IN PATIENTS CO-INFECTED WITH HCVAND HIV: REAL-WORLD HETEROGENEOUS POPULATION FROM THE TRIO NETWORK
    Dieterich, D.
    Bacon, B.
    Curry, M.
    Flamm, S.
    Guest, L.
    Kowdley, K.
    Lee, Y.
    Tsai, N.
    Younossi, Z.
    Afdhal, N.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S756 - S757
  • [35] Clinical decompensation after achieving SVR with sofosbuvir, daclatasvir and ribavirin in a patient with recurrent HCV post-liver transplant
    Kalafateli, Maria
    Dusheiko, Geoffrey
    Manousou, Pinelopi
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2015, 24 (02) : 257 - 258
  • [36] Ledipasvir/Sofosbuvir with Ribavirin for the Treatment of HCV in Patients with Post Transplant Recurrence: Preliminary Results of a Prospective, Multicenter Study
    Reddy, K. Rajender
    Everson, Gregory T.
    Flamm, Steven L.
    Denning, Jill M.
    Arterburn, Sarah
    Brandt-Sarif, Theo
    Pang, Phillip S.
    McHutchison, John G.
    Curry, Michael P.
    Charlton, Michael
    HEPATOLOGY, 2014, 60 : 200A - 201A
  • [37] A real-world study of treating advanced liver cirrhosis due to chronic HCV infection genotype 1b with sofosbuvir plus ledipasvir with or without ribavirin: results from a cohort of 349 patients
    Preda, Carmen Monica
    Gheorghe, Liana
    Istratescu, Doina
    Manuc, Mircea
    Pop, Corina
    Andreea, Grigore
    Iacob, Speranta
    Manuc, Teodora
    Tugui, Letita
    Tieranu, Cristian
    Diculescu, Mircea Mihai
    Iliescu, Elena Laura
    JOURNAL OF HEPATOLOGY, 2020, 73 : S334 - S334
  • [38] Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort
    Lacombe, Karine
    Fontaine, Helene
    Dhiver, Catherine
    Metivier, Sophie
    Rosenthal, Eric
    Antonini, Teresa
    Valantin, Marc Antoine
    Miailhes, Patrick
    Harent, Stanislas
    Batisse, Dominique
    Pageaux, Georges-Philippe
    Chas, Julie
    Aumaitre, Hugues
    Dominguez, Stephanie
    Allegre, Thierry
    Lafeuillade, Alain
    Billaud, Eric
    De Truchis, Pierre
    Perre, Philippe
    Leroy, Vincent
    De Ledinghen, Victor
    Sogni, Philippe
    Dabis, Francois
    Zhao, Yue
    Filipovics, Anne
    Fedchuk, Larysa
    Akremi, Raoudha
    Bennai, Yacia
    Ceron, Dominique Salmon
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 75 (01) : 97 - 107
  • [39] Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach
    Johnson, Steven W.
    Ammirati, Shelby R.
    Hartis, Charles E.
    Weber, Stephen F.
    Morgan, Michael R.
    Darnell, Timothy A.
    Silwal, Adwait
    Schmidlin, Holly N.
    Priest, David H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (06) : 778 - 781
  • [40] Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir/Sofosbuvir Plus Ribavirin Pretransplant
    Vinaixa, Carmen
    Berenguer, Marina
    ANNALS OF HEPATOLOGY, 2017, 16 (03) : 322 - 323
12345